Form 4: Organon & Co. Executive Susanne Fiedler Reports Stock Transactions
SEC Form 4 Filing
Chief Commercial Officer Susanne Fiedler reports the vesting and conversion of restricted stock units into Organon & Co. common stock, along with a disposition of shares to cover tax obligations.
Summary
- On February 28, 2024, Susanne Fiedler, Chief Commercial Officer of Organon & Co., reported transactions involving Organon & Co. common stock.
- 19,827 restricted stock units vested and were converted into an equal number of common stock shares.
- Fiedler disposed of 6,316 shares at a price of $18.04 to satisfy tax obligations related to the vesting of the restricted stock units.
- Following these transactions, Fiedler directly owns 38,702 shares of Organon & Co. common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common practice and required by the SEC to ensure transparency and prevent insider trading.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they represent routine executive compensation and tax-related dispositions.
Key Dates
| Date | Description |
|---|---|
| 12/31/2023 | Restricted Stock Units vested |
| 02/28/2024 | Restricted Stock Units converted to common stock; shares distributed; tax obligations met through disposition of shares |
| 03/01/2024 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.